Effects of Osteopathic Manipulative Treatment on Neuromuscular Control of the Head-neck System
Status: | Completed |
---|---|
Conditions: | Orthopedic, Pain |
Therapuetic Areas: | Musculoskeletal, Orthopedics / Podiatry |
Healthy: | No |
Age Range: | 21 - 65 |
Updated: | 1/6/2019 |
Start Date: | June 1, 2014 |
End Date: | November 13, 2017 |
The overall goal of this project is to develop sensitive and objective clinical research
tools for the assessment of head-neck motor control. In order to accomplish this goal, the
investigators aim to quantify changes in head-neck motor control before and after osteopathic
manipulative treatment. The investigators hypothesize that head-neck motor control will
improve in neck pain participants after 4-weeks of treatment. Additionally, the investigators
will compare position and force head-neck motor control between healthy controls and neck
pain patients. The investigators hypothesize that baseline tests of position and force
head-neck motor control will be better in healthy individuals than neck pain patients.
tools for the assessment of head-neck motor control. In order to accomplish this goal, the
investigators aim to quantify changes in head-neck motor control before and after osteopathic
manipulative treatment. The investigators hypothesize that head-neck motor control will
improve in neck pain participants after 4-weeks of treatment. Additionally, the investigators
will compare position and force head-neck motor control between healthy controls and neck
pain patients. The investigators hypothesize that baseline tests of position and force
head-neck motor control will be better in healthy individuals than neck pain patients.
Inclusion Criteria:
All participants must meet all of the inclusion criteria to participate in the study. Below
is a list of inclusion criteria for ALL participants:
- Age 21-65 years
- Independently ambulatory
- Able to speak and read English
- Able to understand study procedures and to comply with them for the entire length of
the study.
Below is an additional list of inclusion criteria for NECK PAIN participants:
- Willing to be randomized to either immediate or delayed treatment group.
- Musculoskeletal pain - primarily in the cervical region lasting longer than 3 months
- Pain rating greater than or equal to 3 out of 10 as indicated on the Numeric Rating
Scale for Pain
- Neck Disability greater than or equal to 30% as indicated on the Neck Disability Index
Exclusion Criteria:
All candidates meeting any of the exclusion criteria at baseline will be excluded from
study participation. Exclusion criteria will be self-reported. However, during each
treatment session, the physicians will be watching for clinical signs and symptoms not
consistent with physical findings that are suggestive of the presence of any of the
exclusion criteria. In such a case, further treatment will be discontinued and the subject
will be excluded.
Below is a list of exclusion criteria for ALL participants:
- Inability or unwillingness of individual to give written informed consent.
- Physical therapy or any other form of manual medicine (e.g., Osteopathic Manipulative
Medicine, Chiropractic Manipulation, etc.), acupuncture or spinal injections within
one month prior to study enrollment
- Workers' compensation benefits in the past 3 months or ongoing medical legal issues
- Possibly pregnant
- Extreme obesity (BMI>36)
- Currently using electrical implants (e.g., cardiac pacemakers, drug delivery pumps,
etc.)
History of:
- Spinal surgery
- Spinal fracture
- Spinal infection (e.g., osteomyelitis)
- Cancer
Unresolved symptoms from:
- Head trauma
- Inner ear infection with associated balance and coordination problems
- Orthostatic hypotension
- Uncontrolled hypertension
- Vestibular disorder (e.g. vertigo)
Current diagnosis of:
- Significant spinal deformity (e.g., scoliosis > 20 degrees, torticollis)
- Ankylosing spondylitis
- Spondylolisthesis grades III or IV
- Rheumatoid arthritis
- Osteoporosis
- Angina or congestive heart failure symptoms
- Active bleeding or infection in the back
- Blindness
- Seizures
- Neurologic disease (e.g., Parkinson's disease, multiple sclerosis, cerebral palsy,
Alzheimer's disease, amyotrophic lateral sclerosis, stroke or transient ischemic
attack in the past year, cervical dystonia)
Conditions recognized by a physician any time during the study:
- Significant or worsening signs of neurologic deficit
- Symptoms are not consistent with mechanical findings
- Other conditions impeding protocol implementation
Below is an additional exclusion criterion for healthy control participants:
• Based on the minimal clinically important difference of 2 points (Childs et al., 2005),
"healthy controls" with 2 points or greater pain on NRS will not be eligible to
participate.
We found this trial at
3
sites
Lansing, Michigan 48910
Principal Investigator: Jacek Cholewicki, PhD
Phone: 517-975-3301
Click here to add this to my saved trials
East Lansing, Michigan 48823
Principal Investigator: Jacek Cholewicki, PhD
Phone: 517-975-3301
Click here to add this to my saved trials
Lansing, Michigan 48891
Principal Investigator: Jacek Cholewicki, PhD
Phone: 517-975-3301
Click here to add this to my saved trials